Back
Galectin Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
GALT
Galectin Therapeutics
Last Price:
2.77
Seasonality Move:
36.71%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Galectin Therapeutics Price Quote
$2.77
-0.01 (1.84%)
(Updated: November 23, 2024 at 5:36 AM ET)
Galectin Therapeutics Key Stats
Sell
46
Galectin Therapeutics (GALT)
is a Sell
Day range:
$2.68 - $2.82
52-week range:
$1.56 - $4.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
133.4K
Avg. volume:
143.5K
1-year change:
36.95%
Market cap:
$174.5M
Revenue:
$0
EPS:
$-0.73
How Much Does Galectin Therapeutics Make?
Data Unavailable
Is Galectin Therapeutics Growing As A Company?
Data Unavailable
Galectin Therapeutics Stock Price Performance
-
Did Galectin Therapeutics Stock Go Up Last Month?
Galectin Therapeutics share price went up by 6.11% last month -
Did GALT's Share Price Rise Over The Last Year?
GALT share price rose by 36.95% over the past 1 year
What Is Galectin Therapeutics 52-Week High & Low?
-
What Is Galectin Therapeutics’s 52-Week High Share Price?
Galectin Therapeutics has traded as high as $4.27 over the past 52 weeks -
What Is Galectin Therapeutics’s 52-Week Low Share Price?
Galectin Therapeutics has traded as low as $1.56 over the past 52 weeks
Galectin Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Galectin Therapeutics?
-
How Much Debt Does Galectin Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Galectin Therapeutics Have?
Cash and short term investments quarterly total is $27.1M -
What Is Galectin Therapeutics’s Book Value Per Share?
Book value per share is -1.52
Is Galectin Therapeutics Cash Flow Positive?
-
What Is GALT Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.7M -
What Is Galectin Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $40.4M -
What Is Galectin Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Galectin Therapeutics Return On Invested Capital
Data Unavailable
Galectin Therapeutics Earnings Date & Stock Price
-
What Is Galectin Therapeutics's Stock Price Today?
A single share of GALT can be purchased today for 2.78 -
What Is Galectin Therapeutics’s Stock Symbol?
Galectin Therapeutics trades on the nasdaq under the ticker symbol: GALT -
When Is Galectin Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Galectin Therapeutics is scheduled on March 28, 2025 -
When Is GALT's next ex-dividend date?
Galectin Therapeutics's next ex-dividend date is November 23, 2024 -
How To Buy Galectin Therapeutics Stock?
You can buy Galectin Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Galectin Therapeutics Competitors
-
Who Are Galectin Therapeutics's Competitors?
Below is a list of companies who compete with Galectin Therapeutics or are related in some way:
Galectin Therapeutics Dividend Yield
-
What Is GALT Dividend Yield?
Galectin Therapeutics’s dividend yield currently is 0% -
What Is Galectin Therapeutics’s Payout Ratio?
Galectin Therapeutics’s payout ratio is 0% -
When Did Galectin Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Galectin Therapeutics’s Dividend Per Share?
Galectin Therapeutics pays a dividend of $0.00 per share
Galectin Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 11.00 |
| Upside from Last Price: | 295.68% |